ConductScience.org, home
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
API referenceFor AI assistants

Trial · NCT01977482

Results by group429

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 429

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Change From Baseline in Hemoglobin (Hgb) at Week 4Control-0.64Standard Deviation 0.829grams (g)/deciliter (dL)
Change From Baseline in Hemoglobin (Hgb) at Week 4GSK1278863 4 mg-0.24Standard Deviation 0.989grams (g)/deciliter (dL)
Change From Baseline in Hemoglobin (Hgb) at Week 4GSK1278863 6 mg0.08Standard Deviation 1.131grams (g)/deciliter (dL)
Change From Baseline in Hemoglobin (Hgb) at Week 4GSK1278863 8 mg0.42Standard Deviation 0.796grams (g)/deciliter (dL)
Change From Baseline in Hemoglobin (Hgb) at Week 4GSK1278863 10 mg0.64Standard Deviation 1.177grams (g)/deciliter (dL)
Change From Baseline in Hemoglobin (Hgb) at Week 4GSK1278863 12 mg0.61Standard Deviation 1.245grams (g)/deciliter (dL)
Hgb Concentration at Week 24Control10.56Standard Deviation 0.974g/dL
Hgb Concentration at Week 24GSK1278863 4 mg10.29Standard Deviation 0.864g/dL
Hgb Concentration at Week 24GSK1278863 6 mg10.54Standard Deviation 1.010g/dL
Hgb Concentration at Week 24GSK1278863 8 mg10.63Standard Deviation 1.099g/dL
Hgb Concentration at Week 24GSK1278863 10 mg10.28Standard Deviation 0.856g/dL
Hgb Concentration at Week 24GSK1278863 12 mg10.70Standard Deviation 0.867g/dL
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24ControlPercentage of time within target range54.59Standard Deviation 42.044Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 4 mgPercentage of time within target range74.77Standard Deviation 38.797Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 6 mgPercentage of time within target range57.38Standard Deviation 40.505Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 8 mgPercentage of time within target range37.46Standard Deviation 41.775Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 10 mgPercentage of time within target range48.97Standard Deviation 42.490Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 12 mgPercentage of time within target range55.23Standard Deviation 40.350Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24ControlPercentage of time above target range24.65Standard Deviation 38.556Percentage of days
Percentage of Time Within, Below, and Above Hgb Target Range Between Weeks 20 and 24GSK1278863 4 mgPercentage of time above target range6.89Standard Deviation 22.137Percentage of days

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01977482/results

API referenceFor AI assistants